Open AccessOutcomes by Sex Following Treatment Initiation With Atazanavir Plus Ritonavir or Efavirenz With Abacavir/Lamivudine or Tenofovir/Emtricitabine
Author(s) -
Kimberly Y. Smith,
Camlin Tierney,
Katie R. Mollan,
Charles Venuto,
Chakra Budhathoki,
Ma Qian,
Gene D. Morse,
Paul E. Sax,
David Katzenstein,
Catherine Godfrey,
Margaret A. Fischl,
Eric S. Daar,
Ann C. Collier
Publication year - 2014
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/he3y-dk56
Subject(s) - efavirenz , abacavir , emtricitabine , atazanavir , lamivudine , ritonavir , tenofovir , medicine , virology , pharmacology , human immunodeficiency virus (hiv) , antiretroviral therapy , viral load , hepatitis b virus , virus